BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22479892)

  • 1. [Antenatal ambroxol administration for prevention of respiratopry distress syndrome in preterm infants: preliminary report].
    Marinov B; Jekova N; Andreeva A; Hitrova S
    Akush Ginekol (Sofiia); 2011; 50(4):17-22. PubMed ID: 22479892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of the neonatal lung immaturity].
    Zhekova N; Mikhova M; Nikolov A; Dimitrov A
    Akush Ginekol (Sofiia); 2009; 48(1):11-5. PubMed ID: 19496457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of early ambroxol treatment on lung functions in mechanically ventilated preterm newborns who subsequently developed a bronchopulmonary dysplasia (BPD).
    Schmalisch G; Wauer RR; Böhme B
    Respir Med; 2000 Apr; 94(4):378-84. PubMed ID: 10845438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of respiratory distress syndrome in preterm infants by antenatal ambroxol: a meta-analysis of randomized controlled trials.
    Zhang ZQ; Wu QQ; Huang XM; Lu H
    Am J Perinatol; 2013 Aug; 30(7):529-36. PubMed ID: 23229957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ambroxol for the prevention of respiratory distress syndrome in preterm infants: a meta analysis].
    Zhang ZQ; Huang XM; Lu H
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Nov; 12(11):858-63. PubMed ID: 21083978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of intravenous or atomizing ambroxol for prevention of respiratory distress syndrome in preterm infants].
    Hu Q; Lian JM; Li JQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):301-3. PubMed ID: 16923362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of cellular immunity in newborns after prevention of respiratory distress syndrome (RDS).
    Lazzarin A; Luerti M; Capsoni F; Galli M; Uberti-Foppa C; Zavattini G; Corbella E
    Int J Tissue React; 1986; 8(2):157-65. PubMed ID: 3700005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal use of ambroxol for the prevention of infant respiratory distress syndrome.
    Laoag-Fernandez JB; Fernandez AM; Maruo T
    J Obstet Gynaecol Res; 2000 Aug; 26(4):307-12. PubMed ID: 11049243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cord blood prolactin and thyroid hormone levels after antenatal administration of betamethasone or ambroxol for prevention of respiratory distress syndrome (RDS).
    Luerti M; Spagnolo D; Zavattini G; Bianchi C; Barbera AG; Corbella E
    Biol Res Pregnancy Perinatol; 1984; 5(3):124-9. PubMed ID: 6548163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphonuclear leucocytes functions from premature infants after prevention of respiratory distress syndrome with betamethasone and ambroxol.
    Lazzarin A; Luerti M; Uberti-Foppa C; Zavattini G; Rossi A; Tornaghi R
    Biol Res Pregnancy Perinatol; 1984; 5(3):130-4. PubMed ID: 6478010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induction of fetal lung maturation using ambroxol and betamethasone. Results of an open multicenter study].
    Wolff F; Ponnath H; Wiest W
    Geburtshilfe Frauenheilkd; 1987 Jan; 47(1):19-25. PubMed ID: 3552853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal ambroxol treatment does not prevent the respiratory distress syndrome in premature infants.
    Dani C; Grella PV; Lazzarin L; Rubaltelli FF
    Eur J Pediatr; 1997 May; 156(5):392-3. PubMed ID: 9177984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antenatal ambroxol usage in the prevention of infant respiratory distress syndrome. Beneficial and adverse effects.
    Kimya Y; Küçükkömürcü S; Ozan H; Uncu G
    Clin Exp Obstet Gynecol; 1995; 22(3):204-11. PubMed ID: 7554258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of neonatal respiratory distress syndrome by intra-amniotic administration of pulmonary surfactant.
    Zhang JP; Wang YL; Wang YH; Zhang R; Chen H; Su HB
    Chin Med J (Engl); 2004 Jan; 117(1):120-4. PubMed ID: 14733787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effectiveness of prenatal steroid and ambroxol therapy for the prevention of respiratory distress syndrome in newborns of diabetic mothers].
    Bomba-Opoń DA; Wiczyńska-Zajac A; Domańska-Janczewska E; Kociszewska-Najman B; Marianowski L
    Ginekol Pol; 2000 Aug; 71(8):887-92. PubMed ID: 11082943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Short-term respiratory outcome of late preterm newborn in a center of level III].
    Champion V; Durrmeyer X; Dassieu G
    Arch Pediatr; 2010 Jan; 17(1):19-25. PubMed ID: 19910172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ambroxol versus betamethasone for stimulating antepartal lung maturity--a multicenter study].
    Salzer H; Weidinger H; Simbruner G; Vytiska-Binstorfer E
    Z Geburtshilfe Perinatol; 1986; 190(1):49-59. PubMed ID: 3515786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surfactant and ambroxol in the therapy of idiopathic respiratory syndrome in newborn infants].
    Carrera G; Liberatore A; Riboni G; Clementi M
    Minerva Pediatr; 1991 Nov; 43(11):723-30. PubMed ID: 1791799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of preterm delivery--therapeutic algorithm].
    Marinov B; Andreeva A; Cankova M
    Akush Ginekol (Sofiia); 2011; 50 Suppl 2():31-3. PubMed ID: 22524137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alternative to steroids for prevention of respiratory distress syndrome (RDS): multicenter controlled study to compare ambroxol and betamethasone.
    Luerti M; Lazzarin A; Corbella E; Zavattini G
    J Perinat Med; 1987; 15(3):227-38. PubMed ID: 3323457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.